- Current Status of Brachytherapy for Prostate Cancer - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502731/)
- Quality of life outcomes after brachytherapy for early stage prostate cancer - (https://pubmed.ncbi.nlm.nih.gov/10687991/)
References:
- Current Status of Brachytherapy for Prostate Cancer - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502731/)
- Brachytherapy - (https://www.ncbi.nlm.nih.gov/books/NBK562190/)
- Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635047/)
- Brachytherapy in the therapy of prostate cancer – an interesting choice - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934024/)
- Anaesthesia for brachytherapy - (https://pubmed.ncbi.nlm.nih.gov/18660663/)
- Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials - (https://pubmed.ncbi.nlm.nih.gov/21763066/)
- Iodine-125 and Palladium-103 Low Dose Rate Brachytherapy Seeds Used for Localization of Non-Palpable Lesions - (https://www.nrc.gov/materials/miau/med-use-toolkit/seed-localization.html)
- Brachytherapy as a treatment option for prostate cancer: overview and nursing considerations - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1317044/)
- Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349732/)
- Radiotherapy: Basic Concepts and Recent Advances - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920949/)
- The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy - (https://pubmed.ncbi.nlm.nih.gov/28109634/)
- Brachytherapy in the treatment of cervical cancer: a review- (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045176/)
- Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430680/)
- High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789612/)
- High dose rate brachytherapy as monotherapy for localised prostate cancer - (https://pubmed.ncbi.nlm.nih.gov/29074079/)
- HDR brachytherapy as monotherapy for prostate cancer: A systematic review with meta-analysis - (https://pubmed.ncbi.nlm.nih.gov/33461894/)
- Quality of life outcomes after brachytherapy for early stage prostate cancer - (https://pubmed.ncbi.nlm.nih.gov/10687991/)
- Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience - (https://pubmed.ncbi.nlm.nih.gov/19589580/)
- Management of sexual dysfunction after prostate brachytherapy - (https://pubmed.ncbi.nlm.nih.gov/12599931/)
- Less restrictive patient-specific radiation-safety precautions can be safely prescribed after permanent seed implantation - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819139/)
- Radiation Therapy for Prostate Cancer - (https://www.cancer.org/cancer/prostate-cancer/treating/radiation-therapy.html)
Editor: Dr. Krishanga
Technical: Lingaraj